Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
Mukherjee Jagat J, Gangopadhyay Kalyan K, Subir Ray
Topics & Concepts
PioglitazoneMedicineType 2 Diabetes MellitusDiabetes mellitusType 2 diabetesContext (archaeology)Angiotensin-converting enzyme 2DiseaseThiazolidinedioneCoronavirus disease 2019 (COVID-19)Internal medicineProinflammatory cytokineIntensive care medicinePharmacologyEndocrinologyInflammationInfectious disease (medical specialty)BiologyPaleontologyCOVID-19 Clinical Research StudiesDiabetes Treatment and ManagementPharmacological Receptor Mechanisms and Effects